The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Schneyer Mark C. since 2022.
This trader's CIK number is 1899977.
At the time of last reporting, Schneyer Mark C. was the EVP, CHIEF FINANCIAL OFFICER of Acadia Pharmaceuticals Inc. (stock ticker symbol ACAD).
Also see all insider trading activities at Acadia Pharmaceuticals Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | ACAD | 0 | $0 | 34,150 | $764,722 | 19,621 | $0 |
| 2024 | ACAD | 0 | $0 | 33,392 | $559,780 | 35,161 | $0 |
| 2023 | ACAD | 0 | $0 | 33,885 | $820,089 | 48,171 | $0 |
| 2022 | ACAD | 0 | $0 | 653 | $11,695 | 1,893 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-08-18 | ACAD | Sale | 22,000 | 25.18 | 554,026 |
| 2025-05-16 | ACAD | Sale | 2,000 | 25.00 | 50,000 |
| 2025-05-01 | ACAD | Option Ex | 6,815 | .00 | 0 |
| 2025-05-02 | ACAD | Sale | 3,498 | 14.60 | 51,070 |
| 2025-04-08 | ACAD | Sale | 2,708 | 14.82 | 40,132 |
| 2025-04-05 | ACAD | Option Ex | 5,275 | .00 | 0 |
| 2025-03-25 | ACAD | Option Ex | 6,178 | .00 | 0 |
| 2025-03-26 | ACAD | Sale | 3,171 | 17.05 | 54,065 |
| 2025-02-24 | ACAD | Sale | 773 | 19.96 | 15,429 |
| 2025-02-23 | ACAD | Option Ex | 1,353 | .00 | 0 |
| 2024-11-17 | ACAD | Option Ex | 19,826 | .00 | 0 |
| 2024-11-19 | ACAD | Sale | 10,259 | 16.81 | 172,453 |
| 2024-08-19 | ACAD | Sale | 9,733 | 15.28 | 148,720 |
| 2024-06-08 | ACAD | Option Ex | 1,893 | .00 | 0 |
| 2024-06-10 | ACAD | Sale | 975 | 14.79 | 14,420 |
| 2024-05-02 | ACAD | Sale | 3,503 | 16.94 | 59,340 |
| 2024-05-01 | ACAD | Option Ex | 6,814 | .00 | 0 |
| 2024-04-08 | ACAD | Sale | 2,716 | 17.87 | 48,534 |
| 2024-04-05 | ACAD | Option Ex | 5,275 | .00 | 0 |
| 2024-03-27 | ACAD | Sale | 5,434 | 17.90 | 97,268 |
| 2024-02-26 | ACAD | Sale | 772 | 24.67 | 19,045 |
| 2024-02-23 | ACAD | Option Ex | 1,353 | .00 | 0 |
| 2023-11-20 | ACAD | Sale | 5,108 | 22.64 | 115,645 |
| 2023-11-17 | ACAD | Option Ex | 9,912 | .00 | 0 |
| 2023-08-21 | ACAD | Sale | 10,000 | 29.00 | 289,970 |
| 2023-06-08 | ACAD | Sale | 974 | 25.02 | 24,369 |
| 2023-06-08 | ACAD | Option Ex | 1,893 | .00 | 0 |
| 2023-05-17 | ACAD | Option Ex | 29,738 | .00 | 0 |
| 2023-05-17 | ACAD | Sale | 15,310 | 22.50 | 344,475 |
| 2023-04-05 | ACAD | Option Ex | 5,275 | .00 | 0 |
| 2023-04-06 | ACAD | Sale | 1,916 | 18.16 | 34,794 |
| 2023-02-23 | ACAD | Option Ex | 1,353 | .00 | 0 |
| 2023-02-24 | ACAD | Sale | 577 | 18.78 | 10,836 |
| 2022-06-08 | ACAD | Option Ex | 1,893 | .00 | 0 |
| 2022-06-09 | ACAD | Sale | 653 | 17.91 | 11,695 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Schneyer Mark C. (EVP, CHIEF FINANCIAL OFFICER of Acadia Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.